company-logo

Cellid, Inc. develops immunothetherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and genital cancer with human papilloma virus antigen; BVAC-B for gastric, ovarian, lung, and pancreatic cancer with HER-2/neu antigen; and BVAC-P for prostate, urinary tract, and brain cancer with PAP/PSMA antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; and BVAC-Neo, a customized immunotherapeutic vaccine. Cellid, Inc. was founded in 2006 and is based in Seoul, South Korea.

Cellid Dividend Announcement

Cellid announced a annually dividend of ₩0.28 per ordinary share which will be made payable on . Ex dividend date: 2022-03-15
Cellid's trailing twelve-month (TTM) dividend yield is -%

Cellid Dividend History

Ex-Div dateDividend amountDividend typePay date
2022-03-15₩0.28annually

Cellid Dividend per year

Cellid Dividend Yield

Cellid current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cellid stock? Use our calculator to estimate your expected dividend yield:

Cellid Financial Ratios

P/E ratio-5.33
PEG ratio0.04
P/B ratio1.59
ROE-29.10%
Payout ratio0.00%
Current ratio0.62
Quick ratio0.56
Cash Ratio0.06

Cellid Dividend FAQ

Does Cellid stock pay dividends?
Cellid does not currently pay dividends to its shareholders.
Has Cellid ever paid a dividend?
No, Cellid has no a history of paying dividends to its shareholders. Cellid is not known for its dividend payments.
Why doesn't Cellid pay dividends?
There are several potential reasons why Cellid would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cellid ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cellid has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cellid a dividend aristocrat?
Cellid is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cellid a dividend king?
Cellid is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cellid a dividend stock?
No, Cellid is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cellid stocks?
To buy Cellid you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cellid stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.